about
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleo...
Read More
2.25
0.00
(0.00%)
605.2K
XNAS Volume
XNAS 17 Jul, 2026 4:06 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
PepGen Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..